$235.74
-26.42-10.08%
At close: -
$233.72
-2.02-0.86%
After Hours: 4:45 PM EDT
Comments
Loading...
Alnylam Pharmaceuticals Insider Trading Activity | NASDAQ:ALNY | Benzinga
Track the latest Alnylam Pharmaceuticals insider trading activity. Stay informed on recent buys, sells, and market impact for Alnylam Pharmaceuticals stock.
What is Insider Activity?
Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.
What are Alnylam Pharmaceuticals Inc Insiders Doing?
At Alnylam Pharmaceuticals Inc, recent insider activity has drawn attention. Over the last 30 days, insiders have reported selling a total of 4.32K shares worth $2.64M, meanwhile, insiders have report no purchases in the last 30 days.
Notable Recent Insider Buys and Sales
- On March 3, 2025, Kevin Fitzgerald, the company's CSO & EVP, HEAD RESEARCH sold 496 shares for $241.69 each.
- On March 25, 2025, Pushkal Garg, the company's CMO & EVP DEV & MED AFFAIRS sold 4.32K shares for $167.79 each.
- On January 29, 2025, Pushkal Garg, the company's CMO & EVP DEV & MED AFFAIRS sold 3.72K shares for $186.97 each.
Ownership Statistics for Alnylam Pharmaceuticals Inc
Shares Outstanding
129.427M
Insider Shares Owned
603.671K
Insider Percentage Owned
0.47%
Institutional Shares Held
126.373M
Institutional Percentage Held
97.6%
| Mar 25, 2025 | Pushkal Garg | CMO & EVP DEV & MED AFFAIRS | -4.32K | $167.79 | -$2.64M | SELL | -17.43% | 20.47K | Mar 21 - Mar 24 | View |
| Mar 25, 2025 | David E.I. Pyott | DIRECTOR | 0.00 | $193.97 | -$1.56M | SELL-OPTIONS | 0.00% | 28.04K | Mar 24 | View |
| Mar 05, 2025 | Kevin Fitzgerald | CSO & EVP, HEAD RESEARCH | 1.12K | $242.94 | -$669.30K | GRANT | 8.64% | 14.04K | Mar 03 - Mar 04 | View |
| Mar 05, 2025 | Tolga Tanguler | EVP, CHIEF COMMERCIAL OFFICER | 13.67K | $243.78 | -$114.82K | GRANT | 95.27% | 28.01K | Mar 03 | View |
| Mar 05, 2025 | Pushkal Garg | CMO & EVP DEV & MED AFFAIRS | 11.58K | $242.92 | -$621.15K | GRANT | 87.65% | 24.79K | Mar 03 - Mar 04 | View |
| Mar 05, 2025 | Jeffrey V Poulton | EVP, CHIEF FINANCIAL OFFICER | 13.85K | $243.78 | -$308.14K | GRANT | 40.80% | 47.81K | Mar 03 | View |
| Mar 05, 2025 | Yvonne Greenstreet | CHIEF EXECUTIVE OFFICER | 14.09K | $243.79 | -$945.16K | GRANT | 16.58% | 99.04K | Mar 03 | View |
| Mar 03, 2025 | Yvonne Greenstreet | CHIEF EXECUTIVE OFFICER | 3.02K | $241.69 | -$700.89K | SELL-OPTIONS | 3.69% | 84.95K | Feb 27 - Feb 28 | View |
| Mar 03, 2025 | Jeffrey V Poulton | EVP, CHIEF FINANCIAL OFFICER | 1.11K | $241.70 | -$192.39K | SELL-OPTIONS | 3.39% | 33.95K | Feb 27 - Feb 28 | View |
| Mar 03, 2025 | Tolga Tanguler | EVP, CHIEF COMMERCIAL OFFICER | 1.15K | $241.68 | -$123.98K | SELL-OPTIONS | 8.75% | 14.35K | Feb 27 - Feb 28 | View |
| Mar 03, 2025 | Pushkal Garg | CMO & EVP DEV & MED AFFAIRS | 973.00 | $241.69 | -$225.98K | SELL-OPTIONS | 7.95% | 13.21K | Feb 27 - Feb 28 | View |
| Mar 03, 2025 | Kevin Fitzgerald | CSO & EVP, HEAD RESEARCH | -496.00 | $241.69 | -$119.88K | SELL | -3.70% | 12.92K | Feb 28 | View |
| Feb 18, 2025 | Yvonne Greenstreet | CHIEF EXECUTIVE OFFICER | 2.65K | $255.17 | -$309.53K | GRANT | 3.34% | 81.93K | Feb 13 - Feb 14 | View |
| Feb 18, 2025 | Jeffrey V Poulton | EVP, CHIEF FINANCIAL OFFICER | 2.14K | $255.17 | -$246.75K | GRANT | 6.98% | 32.84K | Feb 13 - Feb 14 | View |
| Feb 18, 2025 | Kevin Fitzgerald | CSO & EVP, HEAD RESEARCH | 0.00 | $252.71 | -$531.45K | GRANT | 0.00% | 13.42K | Feb 13 - Feb 18 | View |
| Feb 18, 2025 | Pushkal Garg | CMO & EVP DEV & MED AFFAIRS | 0.00 | $253.43 | -$787.90K | GRANT | 0.00% | 12.24K | Feb 13 - Feb 18 | View |
| Jan 29, 2025 | Pushkal Garg | CMO & EVP DEV & MED AFFAIRS | -3.72K | $186.97 | -$10.64M | SELL | -23.29% | 12.24K | Jan 27 | View |
| Jan 24, 2025 | Phillip A Sharp | DIRECTOR | 0.00 | $203.11 | -$1.62M | SELL-OPTIONS | 0.00% | 266.90K | Jan 23 | View |
| Dec 13, 2024 | Pushkal Garg | CMO & EVP DEV & MED AFFAIRS | -1.75K | $251.00 | -$439.76K | SELL | -9.89% | 15.96K | Dec 12 | View |
| Nov 27, 2024 | Yvonne Greenstreet | CHIEF EXECUTIVE OFFICER | 5.44K | $250.98 | -$1.31M | GRANT | 7.37% | 79.29K | Nov 25 - Nov 26 | View |
| Nov 27, 2024 | Pushkal Garg | CMO & EVP DEV & MED AFFAIRS | 1.75K | $250.98 | -$422.14K | GRANT | 10.98% | 17.71K | Nov 25 - Nov 26 | View |
| Nov 27, 2024 | Jeffrey V Poulton | EVP, CHIEF FINANCIAL OFFICER | 1.75K | $250.98 | -$422.14K | GRANT | 6.05% | 30.70K | Nov 25 - Nov 26 | View |
| Nov 27, 2024 | Tolga Tanguler | EVP, CHIEF COMMERCIAL OFFICER | 1.53K | $250.98 | -$368.69K | GRANT | 13.13% | 13.19K | Nov 25 - Nov 26 | View |
| Nov 27, 2024 | Kevin Fitzgerald | CSO & EVP, HEAD RESEARCH | 0.00 | $251.65 | -$754.95K | GRANT | 0.00% | 13.42K | Nov 25 - Nov 27 | View |
| Aug 22, 2024 | Yvonne Greenstreet | CHIEF EXECUTIVE OFFICER | 0.00 | $182.50 | -$2.92M | SELL-OPTIONS | 0.00% | 73.85K | Aug 20 | View |
| Aug 14, 2024 | Kevin Fitzgerald | CSO & EVP, HEAD RESEARCH | -1.30K | $180.04 | -$4.12M | SELL | -8.83% | 13.42K | Aug 12 | View |
| Aug 08, 2024 | Dennis A Ausiello | DIRECTOR | 0.00 | $190.84 | -$2.88M | SELL-OPTIONS | 0.00% | 3.64K | Aug 06 | View |
| Aug 02, 2024 | Yvonne Greenstreet | CHIEF EXECUTIVE OFFICER | 0.00 | $177.50 | -$2.80M | SELL-OPTIONS | 0.00% | 73.85K | Aug 01 | View |
| Jul 12, 2024 | Yvonne Greenstreet | CHIEF EXECUTIVE OFFICER | -7.09K | $261.00 | -$1.85M | SELL | -8.76% | 73.85K | Jul 11 | View |
| Jun 27, 2024 | Amy Schulman | DIRECTOR | 0.00 | $185.61 | -$924.72K | SELL-OPTIONS | 0.00% | 8.44K | Jun 25 | View |
| Jun 26, 2024 | David E.I. Pyott | DIRECTOR | 0.00 | $150.72 | -$4.54M | SELL-OPTIONS | 0.00% | 28.04K | Jun 24 | View |
| Jun 26, 2024 | Pushkal Garg | CMO & EVP DEV & MED AFFAIRS | 2.19K | $230.99 | -$485.77K | GRANT | 16.04% | 15.86K | Jun 24 - Jun 25 | View |
| Jun 26, 2024 | Yvonne Greenstreet | CHIEF EXECUTIVE OFFICER | 8.65K | $230.99 | -$1.92M | GRANT | 11.97% | 80.94K | Jun 24 - Jun 25 | View |
| Jun 26, 2024 | Jeffrey V Poulton | EVP, CHIEF FINANCIAL OFFICER | 1.67K | $231.00 | -$370.75K | GRANT | 6.13% | 28.95K | Jun 24 - Jun 25 | View |
| Jun 26, 2024 | Tolga Tanguler | EVP, CHIEF COMMERCIAL OFFICER | 1.67K | $231.00 | -$370.75K | GRANT | 16.75% | 11.66K | Jun 24 - Jun 25 | View |
| Jun 26, 2024 | Kevin Fitzgerald | CSO & EVP, HEAD RESEARCH | 1.30K | $230.99 | -$276.73K | GRANT | 9.69% | 14.72K | Jun 24 - Jun 25 | View |
| May 31, 2024 | Amy Schulman | DIRECTOR | 8.30K | $107.71 | -$1.22M | SELL-OPTIONS | 6102.94% | 8.44K | May 29 | View |
| Mar 01, 2024 | Phillip A Sharp | DIRECTOR | 0.00 | $105.29 | -$2.76M | SELL-OPTIONS | 0.00% | 266.90K | Feb 29 | View |
| Feb 29, 2024 | Tolga Tanguler | EVP, CHIEF COMMERCIAL OFFICER | 1.17K | $155.30 | -$77.81K | SELL-OPTIONS | 28.65% | 5.24K | Feb 27 - Feb 28 | View |
| Feb 29, 2024 | Jeffrey V Poulton | EVP, CHIEF FINANCIAL OFFICER | 1.33K | $155.30 | -$89.14K | SELL-OPTIONS | 7.33% | 19.54K | Feb 27 - Feb 28 | View |
| Feb 29, 2024 | Yvonne Greenstreet | CHIEF EXECUTIVE OFFICER | 2.99K | $155.31 | -$455.36K | SELL-OPTIONS | 6.56% | 48.53K | Feb 27 - Feb 28 | View |
| Feb 29, 2024 | Pushkal Garg | CMO & EVP DEV & MED AFFAIRS | 1.33K | $155.30 | -$89.14K | SELL-OPTIONS | 17.59% | 8.92K | Feb 27 - Feb 28 | View |
| Feb 29, 2024 | Indrani Franchini | EVP, CLO & SECRETARY | 549.00 | $155.30 | -$51.09K | SELL-OPTIONS | 15.32% | 4.13K | Feb 27 - Feb 28 | View |
| Feb 20, 2024 | Pushkal Garg | CMO & EVP DEV & MED AFFAIRS | 2.99K | $148.06 | -$193.67K | GRANT | 65.01% | 7.58K | Feb 15 - Feb 16 | View |
| Feb 20, 2024 | Jeffrey V Poulton | EVP, CHIEF FINANCIAL OFFICER | 2.27K | $148.06 | -$149.10K | GRANT | 14.26% | 18.20K | Feb 15 - Feb 16 | View |
| Feb 20, 2024 | Tolga Tanguler | EVP, CHIEF COMMERCIAL OFFICER | 2.27K | $148.06 | -$149.40K | GRANT | 125.99% | 4.07K | Feb 15 - Feb 16 | View |
| Feb 20, 2024 | Yvonne Greenstreet | CHIEF EXECUTIVE OFFICER | 9.92K | $148.06 | -$1.04M | GRANT | 27.86% | 45.55K | Feb 15 - Feb 16 | View |
| Feb 05, 2024 | Indrani Franchini | EVP, CLO & SECRETARY | 3.58K | $170.99 | -$272.05K | SELL-OPTIONS | ∞ | 3.58K | Feb 01 - Feb 02 | View |
| Dec 29, 2023 | Michael W Bonney | DIRECTOR | 0.00 | $145.72 | -$2.96M | SELL-OPTIONS | 0.00% | 20.03K | Dec 27 | View |
| Aug 07, 2023 | Pushkal Garg | CMO & EVP DEV & MED AFFAIRS | 0.00 | $184.78 | -$1.41M | GRANT | 0.00% | 4.59K | Aug 03 - Aug 07 | View |
| Aug 07, 2023 | Jeffrey V Poulton | EVP, CHIEF FINANCIAL OFFICER | 4.17K | $185.85 | -$643.04K | GRANT | 35.42% | 15.93K | Aug 03 - Aug 04 | View |
| Aug 07, 2023 | Yvonne Greenstreet | CHIEF EXECUTIVE OFFICER | 4.88K | $185.85 | -$753.99K | GRANT | 15.89% | 35.62K | Aug 03 - Aug 04 | View |
| Aug 07, 2023 | Akshay Vaishnaw | PRESIDENT | 4.88K | $185.85 | -$753.99K | GRANT | 26.54% | 23.29K | Aug 03 - Aug 04 | View |
| Aug 04, 2023 | Michael W Bonney | DIRECTOR | 16.03K | $185.38 | -$1.20M | SELL-OPTIONS | 400.73% | 20.03K | Aug 02 - Aug 03 | View |
| Apr 28, 2023 | Yvonne Greenstreet | CHIEF EXECUTIVE OFFICER | 9.34K | $194.59 | -$1.48M | GRANT | 43.63% | 30.74K | Apr 26 - Apr 27 | View |
| Apr 28, 2023 | Jeffrey V Poulton | EVP, CHIEF FINANCIAL OFFICER | 2.30K | $194.59 | -$190.11K | GRANT | 24.31% | 11.76K | Apr 26 - Apr 27 | View |
| Apr 28, 2023 | Tolga Tanguler | EVP, CHIEF COMMERCIAL OFFICER | 1.80K | $194.59 | -$287.21K | GRANT | ∞ | 1.80K | Apr 26 - Apr 27 | View |
| Apr 28, 2023 | Akshay Vaishnaw | PRESIDENT | 2.92K | $194.59 | -$465.46K | GRANT | 18.86% | 18.41K | Apr 26 - Apr 27 | View |
| Apr 28, 2023 | Pushkal Garg | CMO & EVP DEV & MED AFFAIRS | 0.00 | $197.12 | -$846.45K | GRANT | 0.00% | 4.59K | Apr 26 - Apr 28 | View |
| Apr 10, 2023 | Indrani Franchini | EVP, CLO & SECRETARY | -3.50K | $210.00 | -$735.00K | SELL | -100.00% | 0.00 | Apr 06 | View |
| Mar 07, 2023 | Pushkal Garg | CMO & EVP DEV & MED AFFAIRS | -13.07K | $148.22 | -$3.13M | SELL | -73.99% | 4.59K | Mar 03 | View |
| Feb 14, 2023 | Akshay Vaishnaw | PRESIDENT | -7.13K | $139.48 | -$6.27M | SELL | -31.53% | 15.48K | Feb 10 | View |
| Feb 03, 2023 | Indrani Franchini | EVP, CLO & SECRETARY | 3.50K | $226.01 | -$378.56K | SELL-OPTIONS | ∞ | 3.50K | Feb 01 - Feb 02 | View |
| Feb 03, 2023 | Tolga Tanguler | EVP, CHIEF COMMERCIAL OFFICER | 0.00 | $230.19 | -$1.16M | SELL-OPTIONS | 0.00% | 0.00 | Feb 01 - Feb 03 | View |
| Nov 23, 2022 | Dennis A Ausiello | DIRECTOR | 0.00 | $145.55 | -$3.35M | SELL-OPTIONS | 0.00% | 3.50K | Nov 21 | View |
| Aug 17, 2022 | Phillip A Sharp | DIRECTOR | 0.00 | $132.13 | -$6.62M | SELL-OPTIONS | 0.00% | 266.90K | Aug 15 | View |
| Aug 05, 2022 | Tolga Tanguler | EVP, CHIEF COMMERCIAL OFFICER | -1.75K | $206.72 | -$1.11M | SELL | -100.00% | 0.00 | Aug 03 - Aug 05 | View |
| Jul 07, 2022 | Tolga Tanguler | EVP, CHIEF COMMERCIAL OFFICER | -1.75K | $150.00 | -$263.10K | SELL | -50.00% | 1.75K | Jul 05 | View |
| Apr 05, 2022 | Steven M Paul | DIRECTOR | 0.00 | $91.01 | -$2.39M | SELL-OPTIONS | 0.00% | 1.00K | Apr 01 | View |
| Feb 11, 2022 | Phillip A Sharp | DIRECTOR | 0.00 | $80.67 | -$4.16M | SELL-OPTIONS | 0.00% | 266.90K | Feb 09 | View |
| Dec 23, 2021 | Akshay Vaishnaw | PRESIDENT, R&D | 0.00 | $190.03 | -$1.03M | GRANT | 0.00% | 11.73K | Dec 21 - Dec 23 | View |
| Nov 12, 2021 | John Maraganore | CHIEF EXECUTIVE OFFICER | 0.00 | $89.31 | -$5.59M | SELL-OPTIONS | 0.00% | 217.90K | Nov 12 | View |
| Aug 16, 2021 | John Maraganore | CHIEF EXECUTIVE OFFICER | 0.00 | $103.44 | -$6.55M | SELL-OPTIONS | 0.00% | 217.90K | Aug 13 | View |
| Aug 11, 2021 | Akshay Vaishnaw | PRESIDENT, R&D | 0.00 | $131.50 | -$1.48M | SELL-OPTIONS | 0.00% | 11.73K | Aug 09 | View |
| Aug 09, 2021 | Laurie Keating | EVP, CHIEF LEGAL OFFICER | 0.00 | $138.95 | -$1000.00K | SELL-OPTIONS | 0.00% | 5.57K | Aug 05 | View |
| Aug 09, 2021 | Yvonne Greenstreet | PRESIDENT & COO | 0.00 | $138.05 | -$6.47M | SELL-OPTIONS | 0.00% | 11.43K | Aug 06 | View |
| Jul 14, 2021 | Laurie Keating | EVP, CHIEF LEGAL OFFICER | 0.00 | $133.43 | -$620.33K | SELL-OPTIONS | 0.00% | 5.57K | Jul 12 | View |
| Jun 22, 2021 | Akshay Vaishnaw | PRESIDENT, R&D | -2.90K | $118.15 | -$1.85M | SELL | -19.84% | 11.73K | Jun 18 | View |
| Jun 11, 2021 | Laurie Keating | EVP, CHIEF LEGAL OFFICER | -1.73K | $154.00 | -$267.04K | SELL | -23.75% | 5.57K | Jun 09 | View |
| May 17, 2021 | John Maraganore | CHIEF EXECUTIVE OFFICER | 0.00 | $68.94 | -$4.20M | SELL-OPTIONS | 0.00% | 217.90K | May 13 | View |
| Apr 21, 2021 | Akshay Vaishnaw | PRESIDENT, R&D | -3.71K | $135.89 | -$1.19M | SELL | -20.21% | 14.63K | Apr 19 - Apr 21 | View |
| Feb 26, 2021 | John Maraganore | CHIEF EXECUTIVE OFFICER | 0.00 | $77.20 | -$4.76M | SELL-OPTIONS | 0.00% | 209.17K | Feb 25 | View |
| Jan 15, 2021 | Laurie Keating | EVP, CHIEF LEGAL OFFICER | 0.00 | $126.18 | -$789.41K | SELL-OPTIONS | 0.00% | 2.67K | Jan 13 | View |
| Jan 13, 2021 | Laurie Keating | EVP, CHIEF LEGAL OFFICER | -758.00 | $116.37 | -$1.42M | SELL | -22.12% | 2.67K | Jan 11 - Jan 12 | View |
| Jan 13, 2021 | Yvonne Greenstreet | PRESIDENT & COO | 0.00 | $101.61 | -$371.19K | SELL-OPTIONS | 0.00% | 5.23K | Jan 12 | View |
| Dec 22, 2020 | Steven M Paul | — | 0.00 | $74.65 | -$1.96M | OPTION EXERCISE | 0.00% | 1.00K | Dec 18 | View |
| Nov 30, 2020 | Phillip A Sharp | — | 0.00 | $67.10 | -$3.47M | OPTION EXERCISE | 0.00% | 266.90K | Nov 25 | View |
| Nov 20, 2020 | John Maraganore | — | 0.00 | $66.69 | -$4.00M | OPTION EXERCISE | 0.00% | 200.72K | Nov 19 | View |
| Oct 01, 2020 | Akshay Vaishnaw | — | 0.00 | $91.11 | -$94.94K | OPTION EXERCISE | 0.00% | 14.63K | Sep 29 | View |
| Sep 11, 2020 | Barry E Greene | — | -155.00 | $66.19 | -$5.08M | GIFT | -4.91% | 3.00K | Jul 16 - Sep 09 | View |
| Aug 21, 2020 | John Maraganore | — | 0.00 | $72.63 | -$4.41M | OPTION EXERCISE | 0.00% | 200.72K | Aug 20 | View |
| Jul 14, 2020 | Laurie Keating | — | -11.50K | $123.92 | -$4.48M | OPTION EXERCISE | -77.05% | 3.43K | Jul 13 | View |
| Jul 14, 2020 | Yvonne Greenstreet | — | 0.00 | $119.05 | -$3.91M | OPTION EXERCISE | 0.00% | 5.23K | Jul 10 | View |
| Jul 10, 2020 | Yvonne Greenstreet | — | 0.00 | $102.07 | -$1.32M | OPTION EXERCISE | 0.00% | 5.23K | Jul 09 | View |
| Jul 09, 2020 | Barry E Greene | — | 0.00 | $84.56 | -$3.36M | OPTION EXERCISE | 0.00% | 65.72K | Jul 07 | View |
| Jun 24, 2020 | Akshay Vaishnaw | — | 0.00 | $96.64 | -$105.58K | OPTION EXERCISE | 0.00% | 14.63K | Jun 22 | View |
| May 22, 2020 | John Maraganore | — | 0.00 | $76.18 | -$4.66M | OPTION EXERCISE | 0.00% | 200.72K | May 20 | View |
| May 07, 2020 | Barry E Greene | — | 0.00 | $79.56 | -$3.14M | OPTION EXERCISE | 0.00% | 65.72K | May 06 | View |
| May 07, 2020 | Yvonne Greenstreet | — | 0.00 | $110.52 | -$4.41M | OPTION EXERCISE | 0.00% | 5.23K | May 05 - May 06 | View |
| Apr 22, 2020 | Laurie Keating | — | 0.00 | $108.20 | -$616.00K | OPTION EXERCISE | 0.00% | 14.93K | Apr 20 | View |
| Apr 22, 2020 | Akshay Vaishnaw | — | 0.00 | $91.11 | -$2.15M | OPTION EXERCISE | 0.00% | 14.63K | Apr 20 | View |
FAQ
Is insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.